carmustine has been researched along with fotemustine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.25) | 18.7374 |
1990's | 10 (62.50) | 18.2507 |
2000's | 4 (25.00) | 29.6817 |
2010's | 1 (6.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bizzari, JP; Fillastre, JP; Hemet, J; Laquerriere, A; Paraire, M; Paresy, M; Raguenez-Viotte, G | 1 |
Boaziz, C; Breau, JL; Israël, L; Morere, JF | 1 |
Bartosek, I; Corada, M; Garattini, S; Guaitani, A; Lemoine, A; Lucas, C | 1 |
Giroux, B; Hannoun, P; Henzel, D; Meulemans, A; Robine, D | 1 |
Bartosek, I; Corada, M; Dallarda, S; Deloffre, P; Guaitani, A; Lucas, C | 1 |
Bizzari, JP; Deloffre, P; Etienne, MC; Fischel, JL; Formento, P; Frenay, M; Gioanni, J; Milano, G | 1 |
Bizzari, JP; Giroux, B; Hannoun, P; Henzel, D; Meulemans, A; Mohler, J | 1 |
Algermissen, B; Czarnetzki, BM; Kohlmus, CM; Schadendorf, D; Worm, M | 1 |
Ardiet, C; Lind, MJ | 1 |
Boland, I; Gouyette, A; Lacroix, C; Lellouch-Tubiana, A; Margison, GP; Morizet, J; Parker, F; Pierre-Kahn, A; Poullain, MG; Terrier-Lacombe, MJ; Vassal, G; Vénuat, AM; Watson, AJ | 1 |
Feng, XW; Shou, J | 1 |
Branle, F; Camby, I; Geurts-Moespot, A; Jeuken, J; Kiss, R; Lefranc, F; Salmon, I; Sprenger, S; Sweep, F | 1 |
Cupissol, D; Cuq, P; Depeille, P; Evrard, A; Montero, JL; Passagne, I; Vian, L; Winum, JY | 1 |
Audra, P; Cartalat-Carel, S; Colin, P; Ducray, F; Gaucherand, P; Honnorat, J; Mahla, K; Pelissou-Guyotat, I; Trouillas, P | 1 |
Kobiakov, GL | 1 |
Della Puppa, A; Farina, P; Fiduccia, P; Lombardi, G; Pambuku, A; Roma, A; Zagonel, V; Zustovich, F | 1 |
3 review(s) available for carmustine and fotemustine
Article | Year |
---|---|
[Brain metastases of malignant melanomas].
Topics: Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Dacarbazine; Humans; Interleukin-2; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Semustine | 1991 |
Pharmacokinetics of alkylating agents.
Topics: Alkylating Agents; Carmustine; Chlorambucil; Cyclophosphamide; Humans; Ifosfamide; Lomustine; Melphalan; Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Thiotepa | 1993 |
[Clinical significance of mustoforan in management of malignant glioma].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Nitrosourea Compounds; Oligodendroglioma; Organophosphorus Compounds; Semustine; Survival Analysis; Treatment Outcome | 2007 |
13 other study(ies) available for carmustine and fotemustine
Article | Year |
---|---|
Nitrosoureas lomustine, carmustine and fotemustine induced hepatotoxic perturbations in rats: biochemical, morphological and flow cytometry studies.
Topics: Alkaline Phosphatase; Animals; Bilirubin; Carmustine; Cell Cycle; DNA; Dose-Response Relationship, Drug; Flow Cytometry; Liver; Lomustine; Nitrosourea Compounds; Organophosphorus Compounds; Rats; Transaminases | 1991 |
Pharmacokinetics of fotemustine and BCNU in plasma, liver and tumor tissue of rats bearing two lines of Walker 256 carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Carmustine; Cell Line; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Female; Liver; Male; Neoplasm Transplantation; Nitrosourea Compounds; Organophosphorus Compounds; Rats; Rats, Inbred Strains; Sex Characteristics | 1991 |
Comparative diffusion study of two nitrosoureas: carmustine and fotemustine in normal rat brain, human and rat brain biopsies.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Brain; Carmustine; Diffusion; Female; Humans; Male; Microelectrodes; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Rats; Rats, Inbred Strains | 1991 |
Pharmacokinetic profile of fotemustine in rat plasma by electrochemical detection.
Topics: Animals; Brain; Carmustine; Electrochemistry; Hydrogen-Ion Concentration; Kidney; Kinetics; Light; Liver; Lung; Male; Nitrosourea Compounds; Organophosphorus Compounds; Polarography; Rats; Temperature | 1991 |
In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea.
Topics: Antineoplastic Agents; Carmustine; Cell Division; Cisplatin; Dacarbazine; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Lomustine; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Thymidine; Tumor Cells, Cultured | 1990 |
Permeability of two nitrosoureas, carmustine and fotemustine in rat cortex.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Capillary Permeability; Carmustine; Cerebral Cortex; Chromatography, High Pressure Liquid; Endothelium, Vascular; Infusions, Intra-Arterial; Nitrosourea Compounds; Organophosphorus Compounds; Perfusion; Rats; Rats, Inbred Strains | 1989 |
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Carmustine; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fluorouracil; Forecasting; Humans; In Vitro Techniques; Lymphatic Metastasis; Melanoma; Methotrexate; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Remission Induction; Retrospective Studies; Skin Neoplasms; Tumor Cells, Cultured; Vindesine | 1994 |
Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cerebellar Neoplasms; DNA Glycosylases; DNA Repair; Drug Screening Assays, Antitumor; Female; Glioma; Humans; Male; Medulloblastoma; Mice; Middle Aged; N-Glycosyl Hydrolases; Neoplasm Transplantation; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Organophosphorus Compounds; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
[DNA damage induced by fotemustine in cultured HL60 cells].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carmustine; DNA Damage; HL-60 Cells; Humans; Nitrosourea Compounds; Organophosphorus Compounds | 1996 |
Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chromosome Deletion; Chromosomes, Human, Pair 1; Combined Modality Therapy; Dacarbazine; DNA Fingerprinting; DNA, Neoplasm; Glioma; Glutathione Transferase; Humans; Immunohistochemistry; Intermediate Filament Proteins; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Neoplasms, Experimental; Nerve Tissue Proteins; Nestin; Nitrosourea Compounds; Nucleic Acid Hybridization; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Survival Analysis; Temozolomide; Treatment Outcome; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vimentin; Xenograft Model Antitumor Assays | 2002 |
Cytotoxicity, DNA damage, and apoptosis induced by new fotemustine analogs on human melanoma cells in relation to O6-methylguanine DNA-methyltransferase expression.
Topics: Antineoplastic Agents; Apoptosis; Carmustine; DNA Damage; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Guanine; Humans; Melanoma; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Organophosphorus Compounds; Tumor Cells, Cultured | 2003 |
[Management of malignant gliomas diagnosed during pregnancy].
Topics: Abortion, Therapeutic; Adrenal Cortex Hormones; Adult; Algorithms; Anesthesia, General; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbamazepine; Carmustine; Case Management; Cesarean Section; Chemotherapy, Adjuvant; Cranial Irradiation; Craniotomy; Dacarbazine; Female; Frontal Lobe; Glioblastoma; Humans; Infant, Newborn; Intracranial Hypertension; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Paresis; Prednisolone; Pregnancy; Pregnancy Complications, Neoplastic; Prenatal Exposure Delayed Effects; Radiotherapy, Adjuvant; Remission Induction; Supratentorial Neoplasms; Temozolomide; Temporal Lobe | 2006 |
The combination of carmustine wafers and fotemustine in recurrent glioblastoma patients: a monoinstitutional experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Disease-Free Survival; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds | 2014 |